Annaly Capital Management Stock To Go Ex-dividend Tomorrow (NLY)

NEW YORK ( TheStreet) -- The ex-dividend date for Annaly Capital Management (NYSE: NLY) is tomorrow, December 27, 2013. Owners of shares as of market close today will be eligible for a dividend of 30 cents per share. At a price of $10.15 as of 9:50 a.m. ET, the dividend yield is 11.9%.

The average volume for Annaly Capital Management has been 15.3 million shares per day over the past 30 days. Annaly Capital Management has a market cap of $9.58 billion and is part of the financial sector and real estate industry. Shares are down 28% year to date as of the close of trading on Tuesday.

Annaly Capital Management, Inc. owns, manages, and finances a portfolio of real estate related investments in United States.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Annaly Capital Management as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, attractive valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and a generally disappointing performance in the stock itself. You can view the full Annaly Capital Management Ratings Report.

See our dividend calendar or top-yielding stocks list.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Dow Tumbles as Trump Ratchets Up China Trade Fight

Dow Tumbles as Trump Ratchets Up China Trade Fight

Netflix Shares Hit All-Time High as Market Flounders

Netflix Shares Hit All-Time High as Market Flounders

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy